Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellectis (CLLS) Other Accumulated Expenses (2016 - 2023)

Historic Other Accumulated Expenses for Cellectis (CLLS) over the last 11 years, with Q3 2023 value amounting to $9.2 million.

  • Cellectis' Other Accumulated Expenses fell 2097.22% to $9.2 million in Q3 2023 from the same period last year, while for Sep 2023 it was $9.2 million, marking a year-over-year decrease of 2097.22%. This contributed to the annual value of $13.2 million for FY2022, which is 402.01% down from last year.
  • Cellectis' Other Accumulated Expenses amounted to $9.2 million in Q3 2023, which was down 2097.22% from $8.1 million recorded in Q2 2023.
  • In the past 5 years, Cellectis' Other Accumulated Expenses ranged from a high of $19.1 million in Q4 2020 and a low of $4.6 million during Q1 2019
  • For the 5-year period, Cellectis' Other Accumulated Expenses averaged around $11.4 million, with its median value being $11.6 million (2022).
  • As far as peak fluctuations go, Cellectis' Other Accumulated Expenses skyrocketed by 27283.3% in 2020, and later plummeted by 3406.19% in 2023.
  • Cellectis' Other Accumulated Expenses (Quarter) stood at $8.5 million in 2019, then soared by 125.1% to $19.1 million in 2020, then dropped by 28.21% to $13.7 million in 2021, then dropped by 4.02% to $13.2 million in 2022, then plummeted by 30.55% to $9.2 million in 2023.
  • Its Other Accumulated Expenses was $9.2 million in Q3 2023, compared to $8.1 million in Q2 2023 and $6.1 million in Q1 2023.